FDA
-
-
-
-
-
-
-
BioVie completes enrollment in long COVID treatment trial
-
-
-
-
-
-
-
BioVie Announces Abstract Accepted for Presentation at AD/PD 2026
-
-
-
-
-
-
-
Join Biovie’s Exclusive Live Investor Webinar and Q&A Session on December 9
-
-
-
-
-
-
-
BioVie Inc. Announces Closing of $12 Million Public Offering
-
-
-
-
-
-
-
BioVie Appoints Industry Veterans Amy Chappell, MD, FAAN, and Kameel Farag to Board of Directors
-
-
-
-
-
-
-
BioVie to Host Virtual KOL Event to Discuss the Phase 2 Study of Bezisterim for the Treatment of Parkinson's Disease on May 28, 2025
-
-
-
-
-
-
-
ALERT: Grabar Law Office Investigates Claims on Behalf of Shareholders of Axsome Therapeutics, Inc. (NASDAQ: AXSM); BioVie Inc. (NASDAQ: BIVI); Maison Solutions Inc. (NASDAQ: MSS); and Virtu Financial
-
328,337 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

